ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc (XERS)

5.575
-0.055
( -0.98% )
Updated: 15:19:17

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD ($)USD ($)USD ($)USD ($)
Total Revenue 33.2M38.01M48.32M44.39M40.64M48.07M54.27M60.1M
Operating Income -13.28M-15.98M-4.91M-9.84M-14.25M-8.19M-12.89M1.68M
Pre Tax Income -16.83M-20.52M-12.53M-13.63M-18.67M-14.26M-19.06M-5.11M
Net Income -16.83M-19.84M-12.19M-13.39M-18.98M-15.01M-15.74M-5.11M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -11.92M-15.2M-3.98M-7.71M-13.57M-7.59M-12.47M1.68M
EBITDA -10.2M-12.88M-1.81M-6.78M-11.21M-5.2M-9.88M4.7M
Year End December 30 2024 2021202220232024
USD ($)USD ($)USD ($)USD ($)
Total Revenue 49.59M110.25M163.91M203.07M
Operating Income -115.16M-81.94M-44.01M-33.65M
Pre Tax Income -122.73M-96.08M-63.5M-57.1M
Net Income -122.73M-94.66M-62.26M-54.84M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -0.983-0.695-0.451-0.368
EBIT -115.16M-85.1M-38.81M-31.95M
EBITDA -113.28M-69.7M-31.68M-21.58M